Japan Manufacturers Mood Sour as Cost Pressures Bite

Big manufacturers39; business mood at 7 vs f39;cast 6 Big nonmanufacturers39; sentiment at 19 vs f39;cast 17 Mixed data highlights challenges in driving up wages TOKYO, Dec 14 Reuters Japanese manufacturers39; mood soured in the final quarter of 2022 to its lowest in nearly two years, a central bank survey showed, as cost pressures and […]
Read More

German Recession will be Milder than Expected Ifo

BERLIN, Dec 14 Reuters Germany39;s recession will be milder than expected, with the economy expected to contract by 0.1 in 2023 compared to a previous forecast of shrinking by 0.3, the Ifo economic institute said on Wednesday. The economy is expected to grow by 1.8 in 2022 compared to a previous forecast of 1.6. Inflation […]
Read More

Germany Plans Record Debt Issuance as Energy Crisis Bites

BERLIN, Dec 14 Reuters Germany plans record debt issuance of more than 500 billion euros 533 billion next year to fund costs associated with the energy crisis and the fallout from the COVID19 pandemic, German Finance Agency issuance plans published on Wednesday showed. The government intends to issue federal securities with a total volume of about 539 […]
Read More

Italys Leonardo to Repay Early 500mlnEuro Term Loan

ROME, Dec 13 Reuters Italy39;s defence and aerospace group Leonardo announced on Tuesday the early repayment of a 500 million euro 532 million term loan, as part of efforts to reduce debt and the impact of rising interest rates. The company also announced the pricing of the redemption of the entire nominal amount of the 7.375 […]
Read More

Generali Ups Expected Profit Boost from Cattolica Takeover

MILAN, Dec 13 Reuters Italy39;s biggest insurer Generali on Tuesday raised the projected boost to its earnings from last year39;s purchase of smaller rival Cattolica, and ruled out negative impacts from new accounting standards. Generali now expects to achieve pretax synergies of 120130 million euros 127137 million by 2025 from the takeover of Cattolica, compared to […]
Read More

U.S. FDA Approves Miratis Lung Cancer Drug

Dec 12 Reuters The U.S. Food and Drug Administration approved Mirati Therapeutics Inc39;s lung cancer drug adagrasib, the company said on Monday, sending its shares up more than 8 in extended trading. Mirati39;s drug has been approved for treating adult patients with advanced lung cancer as determined by an FDAapproved test, who have received at least […]
Read More